Symrise : Strong organic growth at 12% in Q2, 5% better EBITDA in H1 may leave comparable upside to FY 2022 consensus on raised growth outlook
>Strong 12.0% organic sales growth in Q2 - Symrise reported group sales of €1,170m in Q2 2022, 4% ahead of the consensus of €1,125m (ODDO BHF € 1,080m) and up 22% y-o-y. Organic growth of 12.0% y-o-y was strong and ahead of the consensus of 9.4% (ODDO BHF 8.3%), accelerating from the Q1 2022 level of 8.3% (Q2 2021: 8.8%). Portfolio effects contributed 3pp to y-o-y growth with FX tailwinds at 7%.Taste, nutrition & health remains the growth engine with 14.8...Symrise AG develops, produces, and sells fragrances and flavors as well as active ingredients for the cosmetics industry. Co. operates in two main business segments: The Scent & Care segment, which develops, produces and sells fragrances, cosmetic ingredients, aroma molecules and mint aromas and also develops specific application processes for such substances; and The Flavor & Nutrition segment, which develops, produces and sells flavors that are used by customers in the production of food products (savory and sweet food products as well as dairy products) and beverages.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.